Press Kit for Living with VTE Campaign

Welcome to the press kit for the Living with VTE multimedia campaign. Here you'll find all the resources you need to learn about the campaign and venous thromboembolism (VTE) and its associated conditions of deep vein thrombosis (DVT) and pulmonary embolism (PE). It's our goal with this campaign to educate consumers at risk for and diagnosed with VTE. This reflects one of the missions of the Alliance:  to conduct grassroots education campaigns for health professionals and the public on diseases and conditions that become more prevalent with age. The campaign can be followed on social media using hashtag #LivingwithVTE. For more information about this campaign and for interviews with experts, please contact Noel Lloyd via email or 202.370.7852. 

 Press Release

For immediate release

January 12, 2015
Noel Lloyd
[email protected]

Alliance for Aging Research Releases New Educational Resources on Venous Thromboembolism
Multimedia Living with VTE Campaign Includes Pocket Film

Washington, D.C., January 12, 2015 – The nonprofit Alliance for Aging Research has launched a new campaign to raise awareness about venous thromboembolism (VTE), the third most common cardiovascular illness, and its associated conditions deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE affects more than 600,000 Americans.

Centered on the concept of Living with VTE, the campaign offers easy-to-understand resources to educate about deep vein blood clots and the serious complications that can result from them. These resources highlight risk factors, symptoms, and medical options and empower people at risk with VTE to seek treatment so they can control, manage, and live with their condition.

“VTE can be deadly without treatment. This is especially true when a deep vein clot breaks off and blocks an artery in the lungs, forming a PE,” says Lindsay Clarke, vice president of health programs for the Alliance. “We chose to focus our campaign on Living with VTE because it can be managed and lived with when people are informed about its risk factors and symptoms. We encourage both health care professionals and consumers to access our free resources and spread the word that life with VTE is possible. ”Resources from the campaign include:

  • An animated “pocket film” entitled Living with VTE and Preventing Deadly Blood Clots that offers a quick and accessible overview of causes, symptoms, and treatments in a unique format. A Spanish version is also available.
  • A brochure called Living with VTE that shares in-depth information about VTE, DVT, and PE and guidance on making treatment decisions.
  • An online quiz that tests a person’s knowledge of VTE.

All of these resources can be found here. The Alliance is also releasing information on Twitter at @aging_research using hashtag #LivingwithVTE.

For more information about the campaign, please contact Noel Lloyd, communications manager, at 202.370.7852 or through email.

About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application in order to vastly improve the universal human experience of aging and health. The Alliance was founded in 1986 in Washington, D.C., and has since become a valued advocacy organization and a respected influential voice with policymakers. Visit for more information.


 VTE, DVT, and PE Defined

  • Venous thromboembolism (VTE) is a common cardiovascular condition that involves complications with blood clots in the deep veins. It includes deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Deep vein thrombosis (DVT) is a blood clot that develops in a deep vein in the body—usually within the muscles. The most common place for DVT to develop is in the veins of the legs or pelvis, but it can also generate in the arms, brain, or intestines. Symptoms include: swelling, pain or tenderness, warmth in the swollen area, and/or red or discolored skin.
  • Pulmonary embolism (PE) occurs when blood clots in the deep veins (DVT) break free, travel through the circulatory system to the lungs, and lodge in a main artery or arteries, blocking blood flow. This blockage can cause high blood pressure in the lungs. As a result, the heart pumps harder than usual, and may enlarge and eventually fail from being overworked. Symptoms include: unexplained shortness of breath, pain in the chest, back, or side that is made worse with deep breathing or coughing, rapid breathing, coughing up blood, and/or rapid heartbeat.

 Facts and Figures

  • VTE affects as many as 600,000 Americans and is the third most common cardiovascular illness.
  • Four in 10 DVT clots will develop into PE.
  • One in two cases of VTE will occur during or soon after a person’s discharge from a hospital.
  • Those 85 and over are 15 times more likely to have a VTE event than those ages 45-54.
  • One in 10 people with untreated PE will die within 30 days.
  • Prompt treatment can save lives and includes breaking up the clot through catheter-directed thrombolysis or “clot-busting” medication or preventing the growth of the clot through medication. 

 Campaign Resources